Poseida Therapeutics logo
Poseida Therapeutics PSTX
$ 9.38 -0.37%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Poseida Therapeutics Income Statement 2011-2024 | PSTX

Annual Income Statement Poseida Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

306 M 363 M 424 M 478 M - - - - - - - - -

Shares

90.2 M 72 M 62.2 M 55 M - - - - - - - - -

Historical Prices

3.39 5.04 6.81 11 - - - - - - - - -

Net Income

-123 M -64 M -125 M -130 M -86.5 M -44.4 M -19.7 M - - - - - -

Revenue

64.7 M 130 M 31.2 M - - - 2.98 M - - - - - -

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - -

Operating Income

-130 M -59.9 M -141 M -127 M -85.5 M - - - - - - - -

Interest Expense

8.67 M 6.37 M 3.36 M 3.51 M 3.55 M - - - - - - - -

EBITDA

-124 M -54.8 M -137 M -124 M -77.7 M -38.8 M -20.9 M - - - - - -

Operating Expenses

194 M 190 M 173 M 127 M 78.8 M 40.6 M 24.6 M - - - - - -

General and Administrative Expenses

37.4 M 37.5 M 35.9 M 23 M 18.5 M 9.67 M 5.48 M - - - - - -

All numbers in USD currency

Quarterly Income Statement Poseida Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

97.2 M 97 M 96 M 95.6 M 91.9 M 86.8 M 86.3 M 86 M 76.3 M 62.7 M 62.6 M 62.5 M 62.3 M 62.2 M 62 M 61.9 M 55 M 13.4 M 13.3 M 13.2 M 12.7 M 12.3 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

20.2 M -31.4 M -24.3 M - -31.8 M -27.5 M -38.8 M - 70.4 M -43 M -58.1 M - -42.4 M -45.7 M -38.3 M - -34.4 M -30.4 M -28.8 M - -86.5 M -86.5 M -13.3 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

71.7 M 26 M 28.1 M - 9.35 M 20 M 10.3 M - 116 M 2.7 M 1.44 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

19.7 M -31.8 M -24.6 M - -36.2 M -27.9 M -39.5 M - 71.8 M -41.5 M -57 M - -41.6 M -44.9 M -37.5 M - -33.5 M -29.4 M -28.3 M - -20.8 M -28.3 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

2.3 M 2.26 M 2.25 M - 2.24 M 2.14 M 2.03 M - 1.78 M -1.54 M 1.08 M - 837 K 843 K 838 K - 848 K 892 K 914 K - 935 K 903 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

21 M -30.5 M -23.2 M - -34.8 M -26.5 M -38.2 M - 73.2 M -40.2 M -55.8 M - -40.4 M -43.8 M -36.4 M - -32.8 M -28.9 M -27.9 M - -20 M -27.9 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

52 M 57.7 M 52.7 M - 45.6 M 47.9 M 49.9 M - 44.5 M 44.2 M 58.4 M - 41.6 M 44.9 M 37.5 M - 33.5 M 29.4 M 28.3 M - 20.8 M 28.3 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

10.1 M 12.2 M 9.8 M - 8.09 M 8.68 M 11.8 M - 9.39 M 9.24 M 9.55 M - 9.07 M 8.87 M 8.37 M - 6.46 M 4.24 M 4.85 M - 4.01 M 4.04 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency